Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-03-11

AUTHORS

Yong Wha Moon, Sun Young Rha, Hei-Cheul Jeung, Chan Kim, Min Hee Hong, Hyun Chang, Jae Kyung Roh, Sung Hoon Noh, Byung Soo Kim, Hyun Cheol Chung

ABSTRACT

PurposeWe analyzed the natural history of advanced gastric cancer with sequential salvage chemotherapy following first-line treatment.MethodsWe studied 532 patients with unresectable gastric adenocarcinoma who were treated at Yonsei Cancer Center (2000–2008). The patients were managed with multiple sequential salvage chemotherapy as allowed by performance status and toxicity profiles. The tumor response was assessed every two cycles.ResultsFour hundred sixty patients received palliative chemotherapy and 72 received supportive care only. The median overall survival was 12.0 months for all patients, 12.1 months for the chemotherapy group, and 2.5 months for the supportive care group (P < 0.001). In the chemotherapy group, 87% received first-line chemotherapy, 47% second-line, 23% third-line, 9% fourth-line, and 3% fifth-line. Response rates were 24.8, 12.6, 10.9, 2.6, and 0% and disease control rates were 76.3, 60.1, 54.2, 54.2, and 53.3% for first- to fifth-line treatment, respectively. The median progression-free survival was 5.5, 3.4, 2.5, 1.9, and 2.0 months and overall survival was 12.1, 7.9, 5.5, 5.0, and 6.8 months. Performance status and metastatic pattern were consistent prognostic factors throughout salvage treatment.ConclusionsClinical trials may be feasible in second- or third-line salvage chemotherapy for gastric cancer. Future clinical trials in these settings should take into account the low response rate, short progression-free survival, and the prognostic factors for optimal trial design. More... »

PAGES

797-805

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-010-1295-z

DOI

http://dx.doi.org/10.1007/s00280-010-1295-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037373409

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20221831


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endpoint Determination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Palliative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomach Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, 120-752, Seodaemun-gu, Seoul, Korea", 
            "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moon", 
        "givenName": "Yong Wha", 
        "id": "sg:person.0706167144.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706167144.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, 120-752, Seodaemun-gu, Seoul, Korea", 
            "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
            "Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rha", 
        "givenName": "Sun Young", 
        "id": "sg:person.01036404665.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036404665.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Medical Oncology, Department of Internal Medicine, Kangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, 120-752, Seodaemun-gu, Seoul, Korea", 
            "Division of Medical Oncology, Department of Internal Medicine, Kangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeung", 
        "givenName": "Hei-Cheul", 
        "id": "sg:person.01276364570.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276364570.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Chan", 
        "id": "sg:person.01274627441.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274627441.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hong", 
        "givenName": "Min Hee", 
        "id": "sg:person.01274707460.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274707460.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chang", 
        "givenName": "Hyun", 
        "id": "sg:person.01050766347.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050766347.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, 120-752, Seodaemun-gu, Seoul, Korea", 
            "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
            "Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roh", 
        "givenName": "Jae Kyung", 
        "id": "sg:person.0767622633.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, 120-752, Seodaemun-gu, Seoul, Korea", 
            "Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea", 
            "Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noh", 
        "givenName": "Sung Hoon", 
        "id": "sg:person.01120377020.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120377020.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, 120-752, Seodaemun-gu, Seoul, Korea", 
            "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Byung Soo", 
        "id": "sg:person.01073443534.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073443534.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, 120-752, Seodaemun-gu, Seoul, Korea", 
            "Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
            "Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "Hyun Cheol", 
        "id": "sg:person.016554426212.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016554426212.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6600345", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009389459", 
          "https://doi.org/10.1038/sj.bjc.6600345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10038-007-0186-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004094324", 
          "https://doi.org/10.1007/s10038-007-0186-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.114", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030614602", 
          "https://doi.org/10.1038/bjc.1995.114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6604732", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007286952", 
          "https://doi.org/10.1038/sj.bjc.6604732"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020964423", 
          "https://doi.org/10.1038/sj.bjc.6602575"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-03-11", 
    "datePublishedReg": "2010-03-11", 
    "description": "PurposeWe analyzed the natural history of advanced gastric cancer with sequential salvage chemotherapy following first-line treatment.MethodsWe studied 532 patients with unresectable gastric adenocarcinoma who were treated at Yonsei Cancer Center (2000\u20132008). The patients were managed with multiple sequential salvage chemotherapy as allowed by performance status and toxicity profiles. The tumor response was assessed every two cycles.ResultsFour hundred sixty patients received palliative chemotherapy and 72 received supportive care only. The median overall survival was 12.0\u00a0months for all patients, 12.1\u00a0months for the chemotherapy group, and 2.5\u00a0months for the supportive care group (P\u00a0<\u00a00.001). In the chemotherapy group, 87% received first-line chemotherapy, 47% second-line, 23% third-line, 9% fourth-line, and 3% fifth-line. Response rates were 24.8, 12.6, 10.9, 2.6, and 0% and disease control rates were 76.3, 60.1, 54.2, 54.2, and 53.3% for first- to fifth-line treatment, respectively. The median progression-free survival was 5.5, 3.4, 2.5, 1.9, and 2.0\u00a0months and overall survival was 12.1, 7.9, 5.5, 5.0, and 6.8\u00a0months. Performance status and metastatic pattern were consistent prognostic factors throughout salvage treatment.ConclusionsClinical trials may be feasible in second- or third-line salvage chemotherapy for gastric cancer. Future clinical trials in these settings should take into account the low response rate, short progression-free survival, and the prognostic factors for optimal trial design.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00280-010-1295-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "66"
      }
    ], 
    "keywords": [
      "progression-free survival", 
      "advanced gastric cancer", 
      "salvage chemotherapy", 
      "gastric cancer", 
      "chemotherapy group", 
      "performance status", 
      "overall survival", 
      "prognostic factors", 
      "trial design", 
      "response rate", 
      "median progression-free survival", 
      "third-line salvage chemotherapy", 
      "shorter progression-free survival", 
      "unresectable gastric adenocarcinoma", 
      "supportive care group", 
      "fifth-line treatment", 
      "median overall survival", 
      "first-line chemotherapy", 
      "disease control rate", 
      "first-line treatment", 
      "Yonsei Cancer Center", 
      "consistent prognostic factor", 
      "future clinical trials", 
      "optimal trial design", 
      "low response rate", 
      "palliative chemotherapy", 
      "supportive care", 
      "salvage treatment", 
      "sixty patients", 
      "metastatic pattern", 
      "care group", 
      "Cancer Center", 
      "control rate", 
      "tumor response", 
      "gastric adenocarcinoma", 
      "clinical trials", 
      "toxicity profile", 
      "chemotherapy", 
      "clinical practice", 
      "patients", 
      "ConclusionsClinical trials", 
      "natural history", 
      "months", 
      "cancer", 
      "survival", 
      "treatment", 
      "trials", 
      "group", 
      "status", 
      "adenocarcinoma", 
      "PurposeWe", 
      "MethodsWe", 
      "care", 
      "outcomes", 
      "rate", 
      "factors", 
      "setting", 
      "response", 
      "history", 
      "center", 
      "profile", 
      "practice", 
      "patterns", 
      "implications", 
      "cycle", 
      "design", 
      "account"
    ], 
    "name": "Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design", 
    "pagination": "797-805", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037373409"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-010-1295-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20221831"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-010-1295-z", 
      "https://app.dimensions.ai/details/publication/pub.1037373409"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_503.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00280-010-1295-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1295-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1295-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1295-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1295-z'


 

This table displays all metadata directly associated to this object as RDF triples.

291 TRIPLES      22 PREDICATES      116 URIs      103 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-010-1295-z schema:about N0eb54b6d4b694841b813727511b0e76d
2 N127a15b3889844c9a35d8cce040f9e8b
3 N22b3dc00092a488a87976c31a906b7a6
4 N3060a3657de543c1bb0793074f7e3f65
5 N347f7e340fce496aafd3a49c26c85c1a
6 N4017a321b66247f68c1cab2105abadf1
7 N57a92ea8797a487d96b7b00d4d60b6e6
8 N6123bda093cb483f9d02e488172b4ba7
9 N64aa6c11526e463f8d373703f140d5a7
10 N77bc3d0ecdcc4014a7f864bfe928b8c4
11 N9449f9344a304d58a4bd7d6e3d430c83
12 N99e6232ec6a94f38b1bf6e6e93c5d5fe
13 Nb39c6ba9035a493fbdfa936609c4d8e2
14 Nbebb5fe5a1f94589aa307bcb375052a8
15 Nc50bad75133643b9a08f1010ae2df601
16 Nd54cff01883e40238b10eaa717c974a6
17 Ne40d0e3305de4ac49f25d0e36c17d778
18 Nfc5d33d3b60f4ea18a648b579ba7a44b
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author N70de91c749314a82b054c008740c625b
22 schema:citation sg:pub.10.1007/s10038-007-0186-6
23 sg:pub.10.1038/bjc.1995.114
24 sg:pub.10.1038/sj.bjc.6600345
25 sg:pub.10.1038/sj.bjc.6602575
26 sg:pub.10.1038/sj.bjc.6604732
27 schema:datePublished 2010-03-11
28 schema:datePublishedReg 2010-03-11
29 schema:description PurposeWe analyzed the natural history of advanced gastric cancer with sequential salvage chemotherapy following first-line treatment.MethodsWe studied 532 patients with unresectable gastric adenocarcinoma who were treated at Yonsei Cancer Center (2000–2008). The patients were managed with multiple sequential salvage chemotherapy as allowed by performance status and toxicity profiles. The tumor response was assessed every two cycles.ResultsFour hundred sixty patients received palliative chemotherapy and 72 received supportive care only. The median overall survival was 12.0 months for all patients, 12.1 months for the chemotherapy group, and 2.5 months for the supportive care group (P < 0.001). In the chemotherapy group, 87% received first-line chemotherapy, 47% second-line, 23% third-line, 9% fourth-line, and 3% fifth-line. Response rates were 24.8, 12.6, 10.9, 2.6, and 0% and disease control rates were 76.3, 60.1, 54.2, 54.2, and 53.3% for first- to fifth-line treatment, respectively. The median progression-free survival was 5.5, 3.4, 2.5, 1.9, and 2.0 months and overall survival was 12.1, 7.9, 5.5, 5.0, and 6.8 months. Performance status and metastatic pattern were consistent prognostic factors throughout salvage treatment.ConclusionsClinical trials may be feasible in second- or third-line salvage chemotherapy for gastric cancer. Future clinical trials in these settings should take into account the low response rate, short progression-free survival, and the prognostic factors for optimal trial design.
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf Na46c68cc5d93441e81abf2f6cc2bc247
34 Nca5aee749ba94ebe891ccfe797d15e70
35 sg:journal.1088364
36 schema:keywords Cancer Center
37 ConclusionsClinical trials
38 MethodsWe
39 PurposeWe
40 Yonsei Cancer Center
41 account
42 adenocarcinoma
43 advanced gastric cancer
44 cancer
45 care
46 care group
47 center
48 chemotherapy
49 chemotherapy group
50 clinical practice
51 clinical trials
52 consistent prognostic factor
53 control rate
54 cycle
55 design
56 disease control rate
57 factors
58 fifth-line treatment
59 first-line chemotherapy
60 first-line treatment
61 future clinical trials
62 gastric adenocarcinoma
63 gastric cancer
64 group
65 history
66 implications
67 low response rate
68 median overall survival
69 median progression-free survival
70 metastatic pattern
71 months
72 natural history
73 optimal trial design
74 outcomes
75 overall survival
76 palliative chemotherapy
77 patients
78 patterns
79 performance status
80 practice
81 profile
82 prognostic factors
83 progression-free survival
84 rate
85 response
86 response rate
87 salvage chemotherapy
88 salvage treatment
89 setting
90 shorter progression-free survival
91 sixty patients
92 status
93 supportive care
94 supportive care group
95 survival
96 third-line salvage chemotherapy
97 toxicity profile
98 treatment
99 trial design
100 trials
101 tumor response
102 unresectable gastric adenocarcinoma
103 schema:name Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design
104 schema:pagination 797-805
105 schema:productId N81b25039c2044d729e37f7a2c99e8061
106 N9572845dbb32449d997d05359c50df0b
107 Nb16dbc5ed8144099b6886ccab5625418
108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037373409
109 https://doi.org/10.1007/s00280-010-1295-z
110 schema:sdDatePublished 2022-05-20T07:25
111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
112 schema:sdPublisher Nf9d0b8c6dffd4d158c777dc404b8d03e
113 schema:url https://doi.org/10.1007/s00280-010-1295-z
114 sgo:license sg:explorer/license/
115 sgo:sdDataset articles
116 rdf:type schema:ScholarlyArticle
117 N071452d98802496f8cea17c6d473d579 rdf:first sg:person.01036404665.54
118 rdf:rest Na18598b6425249f2b663faa353493db1
119 N0eb54b6d4b694841b813727511b0e76d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Research Design
121 rdf:type schema:DefinedTerm
122 N127a15b3889844c9a35d8cce040f9e8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Antineoplastic Agents
124 rdf:type schema:DefinedTerm
125 N22b3dc00092a488a87976c31a906b7a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Male
127 rdf:type schema:DefinedTerm
128 N3060a3657de543c1bb0793074f7e3f65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Young Adult
130 rdf:type schema:DefinedTerm
131 N347f7e340fce496aafd3a49c26c85c1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 N4017a321b66247f68c1cab2105abadf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Middle Aged
136 rdf:type schema:DefinedTerm
137 N57a92ea8797a487d96b7b00d4d60b6e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Adult
139 rdf:type schema:DefinedTerm
140 N5c0a5afd301b4f599d75ea16b485be70 rdf:first sg:person.0767622633.82
141 rdf:rest N83c76cae6cad44baae4ad51d37ad3464
142 N6123bda093cb483f9d02e488172b4ba7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Salvage Therapy
144 rdf:type schema:DefinedTerm
145 N64aa6c11526e463f8d373703f140d5a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Stomach Neoplasms
147 rdf:type schema:DefinedTerm
148 N6e59efbab7a343a8bae7bef0aac1a1df rdf:first sg:person.01073443534.33
149 rdf:rest Nb962facf7db04903aa8b36ca963746be
150 N70de91c749314a82b054c008740c625b rdf:first sg:person.0706167144.03
151 rdf:rest N071452d98802496f8cea17c6d473d579
152 N77bc3d0ecdcc4014a7f864bfe928b8c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Treatment Outcome
154 rdf:type schema:DefinedTerm
155 N81b25039c2044d729e37f7a2c99e8061 schema:name pubmed_id
156 schema:value 20221831
157 rdf:type schema:PropertyValue
158 N83c76cae6cad44baae4ad51d37ad3464 rdf:first sg:person.01120377020.04
159 rdf:rest N6e59efbab7a343a8bae7bef0aac1a1df
160 N9449f9344a304d58a4bd7d6e3d430c83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Aged
162 rdf:type schema:DefinedTerm
163 N9572845dbb32449d997d05359c50df0b schema:name dimensions_id
164 schema:value pub.1037373409
165 rdf:type schema:PropertyValue
166 N99e6232ec6a94f38b1bf6e6e93c5d5fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Retrospective Studies
168 rdf:type schema:DefinedTerm
169 Na18598b6425249f2b663faa353493db1 rdf:first sg:person.01276364570.14
170 rdf:rest Nf423d9f924754daeb8936ae79487b09c
171 Na46c68cc5d93441e81abf2f6cc2bc247 schema:issueNumber 4
172 rdf:type schema:PublicationIssue
173 Nb16dbc5ed8144099b6886ccab5625418 schema:name doi
174 schema:value 10.1007/s00280-010-1295-z
175 rdf:type schema:PropertyValue
176 Nb39c6ba9035a493fbdfa936609c4d8e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Survival Analysis
178 rdf:type schema:DefinedTerm
179 Nb962facf7db04903aa8b36ca963746be rdf:first sg:person.016554426212.74
180 rdf:rest rdf:nil
181 Nbebb5fe5a1f94589aa307bcb375052a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Endpoint Determination
183 rdf:type schema:DefinedTerm
184 Nc50bad75133643b9a08f1010ae2df601 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Aged, 80 and over
186 rdf:type schema:DefinedTerm
187 Nca5aee749ba94ebe891ccfe797d15e70 schema:volumeNumber 66
188 rdf:type schema:PublicationVolume
189 Nd04a9b2d429e4ed894869fdee41edf56 rdf:first sg:person.01050766347.58
190 rdf:rest N5c0a5afd301b4f599d75ea16b485be70
191 Nd54cff01883e40238b10eaa717c974a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Female
193 rdf:type schema:DefinedTerm
194 Ne40d0e3305de4ac49f25d0e36c17d778 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Prognosis
196 rdf:type schema:DefinedTerm
197 Nf423d9f924754daeb8936ae79487b09c rdf:first sg:person.01274627441.40
198 rdf:rest Nf45c76f9de734c10b4f7c1955dad780b
199 Nf45c76f9de734c10b4f7c1955dad780b rdf:first sg:person.01274707460.58
200 rdf:rest Nd04a9b2d429e4ed894869fdee41edf56
201 Nf9d0b8c6dffd4d158c777dc404b8d03e schema:name Springer Nature - SN SciGraph project
202 rdf:type schema:Organization
203 Nfc5d33d3b60f4ea18a648b579ba7a44b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Palliative Care
205 rdf:type schema:DefinedTerm
206 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
207 schema:name Medical and Health Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
210 schema:name Oncology and Carcinogenesis
211 rdf:type schema:DefinedTerm
212 sg:journal.1088364 schema:issn 0344-5704
213 1432-0843
214 schema:name Cancer Chemotherapy and Pharmacology
215 schema:publisher Springer Nature
216 rdf:type schema:Periodical
217 sg:person.01036404665.54 schema:affiliation grid-institutes:grid.15444.30
218 schema:familyName Rha
219 schema:givenName Sun Young
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036404665.54
221 rdf:type schema:Person
222 sg:person.01050766347.58 schema:affiliation grid-institutes:grid.15444.30
223 schema:familyName Chang
224 schema:givenName Hyun
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050766347.58
226 rdf:type schema:Person
227 sg:person.01073443534.33 schema:affiliation grid-institutes:grid.15444.30
228 schema:familyName Kim
229 schema:givenName Byung Soo
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073443534.33
231 rdf:type schema:Person
232 sg:person.01120377020.04 schema:affiliation grid-institutes:grid.15444.30
233 schema:familyName Noh
234 schema:givenName Sung Hoon
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120377020.04
236 rdf:type schema:Person
237 sg:person.01274627441.40 schema:affiliation grid-institutes:grid.15444.30
238 schema:familyName Kim
239 schema:givenName Chan
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274627441.40
241 rdf:type schema:Person
242 sg:person.01274707460.58 schema:affiliation grid-institutes:grid.15444.30
243 schema:familyName Hong
244 schema:givenName Min Hee
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274707460.58
246 rdf:type schema:Person
247 sg:person.01276364570.14 schema:affiliation grid-institutes:grid.15444.30
248 schema:familyName Jeung
249 schema:givenName Hei-Cheul
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276364570.14
251 rdf:type schema:Person
252 sg:person.016554426212.74 schema:affiliation grid-institutes:grid.15444.30
253 schema:familyName Chung
254 schema:givenName Hyun Cheol
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016554426212.74
256 rdf:type schema:Person
257 sg:person.0706167144.03 schema:affiliation grid-institutes:grid.15444.30
258 schema:familyName Moon
259 schema:givenName Yong Wha
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706167144.03
261 rdf:type schema:Person
262 sg:person.0767622633.82 schema:affiliation grid-institutes:grid.15444.30
263 schema:familyName Roh
264 schema:givenName Jae Kyung
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82
266 rdf:type schema:Person
267 sg:pub.10.1007/s10038-007-0186-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004094324
268 https://doi.org/10.1007/s10038-007-0186-6
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/bjc.1995.114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030614602
271 https://doi.org/10.1038/bjc.1995.114
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/sj.bjc.6600345 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009389459
274 https://doi.org/10.1038/sj.bjc.6600345
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/sj.bjc.6602575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020964423
277 https://doi.org/10.1038/sj.bjc.6602575
278 rdf:type schema:CreativeWork
279 sg:pub.10.1038/sj.bjc.6604732 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007286952
280 https://doi.org/10.1038/sj.bjc.6604732
281 rdf:type schema:CreativeWork
282 grid-institutes:grid.15444.30 schema:alternateName Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
283 Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
284 Division of Medical Oncology, Department of Internal Medicine, Kangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
285 Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
286 schema:name Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
287 Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, 120-752, Seodaemun-gu, Seoul, Korea
288 Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
289 Division of Medical Oncology, Department of Internal Medicine, Kangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
290 Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
291 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...